20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1878L | PACAP 1-38 acetate | PACAP | |
PACAP 1-38 acetate is a pituitary adenylate cyclase activating polypeptide (PACAP) analogue. PACAP 1-38 acetate binds to PACAP type I receptor(IC50 = 4 nM) and PACAP type II VIP2 receptor(IC50 = 1 nM) but not to PACAP ty... | |||
TP1070L | PACAP (1-27), human, ovine, rat acetate | PACAP 1-27 acetate,PACAP (1-27), human, ovine, rat acetate(127317-03-7 free base) | PACAP |
PACAP (1-27), human, ovine, rat acetate (PACAP 1-27 acetate) is a novel neuropeptides originally isolated from bovine hypothalamus, also found in humans and rats. | |||
TP1618L | PACAP-38 (31-38), human, mouse, rat acetate | PACAP-38 (31-38), human, mouse, rat acetate(138764-85-9 Free base) | PACAP |
PACAP-38 (31-38), human, mouse, rat acetate is an activator of PAC1 receptor. PACAP-38 (31-38), human, mouse, rat acetate demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY an... | |||
TP1722L | PACAP (6-38), human, ovine, rat acetate | PACAP | |
PACAP (6-38), human, ovine, rat acetate is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively. | |||
TP1070 | PACAP (1-27), human, ovine, rat | PACAP 1-27 | |
PACAP (1-27) (the N-terminal fragment of PACAP-38) is a novel neuropeptides originally isolated from bovine hypothalamus, also found in humans and rats. | |||
TP1069 | PACAP (1-27), human, ovine, rat TFA | PACAP 1-27 TFA | |
PACAP (1-27), human, ovine, rat TFA (PACAP 1-27 TFA) is an N-terminal fragment of pacap-38 and an effective PACAP receptor antagonist. The IC50s for rat PAC1, rat VPAC1 and human VPAC2 are 3nm, 2nm and 5nm respectively. | |||
T83510 | [Arg-15,20,21,Leu17]-PACAP-Gly-Lys-Arg-NH2 | BM-PACAP | |
[Arg-15,-20,-21, Leu17]-PACAP-Gly-Lys-Arg-NH2 (BM-PACAP) is a synthetic analogue of PACAP 1-27 that exhibits a relaxant effect [1]. | |||
TP1878 | PACAP (1-38), human, ovine, rat | Pituitary Adenylate Cyclase Activating Polypeptide 38,PACAP 1-38 | PACAP |
PACAP (1-38), human, ovine, rat (Pituitary Adenylate Cyclase Activating Polypeptide 38) is a neuropeptide with 38 amino acid residues. | |||
T36428 | PACAP-related Peptide (human) (trifluoroacetate salt) | PACAP | |
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adeny... | |||
T37435 | PACAP-related Peptide (rat) (trifluoroacetate salt) | PACAP | |
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adeny... | |||
TP1722 | PACAP (6-38), human, ovine, rat | ||
PACAP (6-38), human, ovine, rat is a potent antagonist of PACAP 38. PACAP (6-38) is much more potent and selective than PACAP (6-27) in the inhibition of PACAP-27-stimulated pituitary adenylate cyclase. | |||
TP1438 | PACAP (6-38), human, ovine, rat TFA | ||
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively. | |||
TP1850 | PACAP-Related Peptide (PRP), human | ||
PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies. | |||
T36427 | PACAP (6-27) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt) | PACAP | |
Pituitary adenylate cyclase-activating peptide (PACAP) (6-27) is a PACAP receptor antagonist with IC50 values of 1,500, 600, and 300 nM, respectively, for rat PAC1, rat VPAC1, and human VPAC2 recombinant receptors expres... | |||
TP1618 | PACAP-38 (31-38), human, mouse, rat | ||
PACAP-38 (31-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production. | |||
TP1619 | PACAP-38 (16-38), human, mouse, rat | ||
PACAP-38 (16-38), human, mouse, rat demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal NPY and catecholamine production. | |||
TP1054 | PACAP (1-38), human, ovine, rat TFA | Pituitary Adenylate Cyclase Activating Polypeptide 38 (TFA) | |
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP... | |||
TP1414 | PACAP-38 (31-38), human, mouse, rat TFA | ||
PACAP-38 (31-38), human, mouse, rat (TFA) demonstrates potent, efficacious, and sustained stimulatory effects on sympathetic neuronal. | |||
T81572 | PACAP (1-38) free acid | ||
PACAP (1-38) free acid, an endogenous neuropeptide, potently modulates gastrointestinal and neuroendocrine functions. It enhances antral motility, increases somatostatin secretion, and stimulates the release of vasoactiv... | |||
T80069 | PACAP (6-27) (human, ovine, rat) | Pituitary adenylate cyclase-activating peptide (6-27) | |
PACAP (6-27) (human, ovine, rat) serves as an antagonist for the PACAP receptor, inhibiting the catecholamine response of the canine adrenal gland to vasoactive intestinal peptide (VIP). This compound holds promise for r... |